• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.

作者信息

Storey Robert F

机构信息

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK

Directorate of Cardiology and Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

出版信息

Heart. 2021 Jul;107(14):1111-1112. doi: 10.1136/heartjnl-2020-318872. Epub 2021 Mar 19.

DOI:10.1136/heartjnl-2020-318872
PMID:33741579
Abstract
摘要

相似文献

1
Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
Heart. 2021 Jul;107(14):1111-1112. doi: 10.1136/heartjnl-2020-318872. Epub 2021 Mar 19.
2
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.替格瑞洛或普拉格雷在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中的应用。
Circulation. 2020 Dec 15;142(24):2329-2337. doi: 10.1161/CIRCULATIONAHA.120.050244. Epub 2020 Oct 29.
3
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.急性冠状动脉综合征患者接受经皮冠状动脉介入治疗时使用氯吡格雷、普拉格雷或替卡格雷的情况。
Intern Med J. 2016 May;46(5):559-65. doi: 10.1111/imj.13041.
4
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.经皮冠状动脉介入治疗的急性心肌梗死患者在院内使用二磷酸腺苷受体抑制剂的转换：来自TRANSLATE-ACS研究对当代实践的见解
Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):499-508. doi: 10.1177/2048872614564082. Epub 2014 Dec 16.
5
Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.接受经皮冠状动脉介入治疗的普拉格雷与氯吡格雷治疗急性冠状动脉综合征患者的比较：瑞士急性心肌梗死（AMIS）-Plus注册研究的倾向评分匹配分析。
Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):13-22. doi: 10.1177/2048872614566946. Epub 2015 Jan 22.
6
Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).经皮冠状动脉介入治疗后使用替格瑞洛与普拉格雷治疗的医疗保险患者（≥65岁）的90天再入院率和长期死亡率（来自密歇根蓝十字蓝盾心血管联盟）
Am J Cardiol. 2017 Dec 1;120(11):1926-1932. doi: 10.1016/j.amjcard.2017.08.009. Epub 2017 Aug 30.
7
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.比较替格瑞洛与普拉格雷对需冠脉支架置入的非 ST 段抬高型急性冠脉综合征合并糖尿病患者炎症、血管功能和循环内皮祖细胞的影响：一项前瞻性、随机、交叉试验。
JACC Cardiovasc Interv. 2017 Aug 28;10(16):1646-1658. doi: 10.1016/j.jcin.2017.05.064.
8
Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different P2Y inhibitors in a large observational study.一项大型观察性研究比较了经皮冠状动脉介入治疗的急性冠状动脉综合征患者使用不同 P2Y 抑制剂的处方率和临床结局。
Int J Cardiol. 2019 Jan 1;274:21-26. doi: 10.1016/j.ijcard.2018.09.011. Epub 2018 Sep 5.
9
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.替格瑞洛或普拉格雷在急性冠状动脉综合征患者中的应用。
N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1.
10
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.经皮冠状动脉介入治疗患者中坎格雷洛、普拉格雷、替格瑞洛和氯吡格雷的比较：一项网状Meta分析。
Cardiovasc Revasc Med. 2017 Mar;18(2):79-85. doi: 10.1016/j.carrev.2016.10.005. Epub 2016 Oct 21.

引用本文的文献

1
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report.卡泊单抗治疗在双联抗血小板治疗和抗凝治疗有效情况下仍发生的亚急性支架内血栓形成：一例报告
Eur Heart J Case Rep. 2023 Jan 18;7(2):ytac497. doi: 10.1093/ehjcr/ytac497. eCollection 2023 Feb.